Fujirebio continues to work and build relationships with global researchers, key opinion leaders and leading institutes to expand our partners access to novel technology.
Fujirebio has invested in technology that has enabled the expansion of our small- and large-scale production of antibodies. Capabilities provided to our partners include custom services spanning the creation of master and working cell banks, characterization, and small-scale testing of prototypes, to kg scale manufacturing of antibody.
Contact us about your CDMO project
Would you like to obtain more information or do you have a project for which you need support?
